Sign In to Follow Application
View All Documents & Correspondence

"Improved Process For The Preparation Of 1, 5 Dihydro 4 H Pyrazolo [3, 4 D] Pyrimidin 4 One"

Abstract: "IMPROVED PROCESS FOR THE PREPARATION OF 1, 5-DIHYDRO-4 H-PYRAZOLO [3, 4- D] PYRIMIDIN-4-ONE" The present invention relates to an improved process for the preparation of 1, 5- dihydro-4 H-pyrazolo [3, 4- d] pyrimidin-4-one (1), having purity greater than 99.5% by High performance liquid chromatography (HPLC). Allopurinol (1)

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
30 January 2023
Publication Number
31/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

Biophore India pharmaceuticals Pvt. Ltd
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.

Inventors

1. Manik Reddy Pullagurla
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.
2. Bhaskar Reddy Pitta
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.
3. Bharath Reddy Gajjala
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.
4. Jagadeesh Babu Rangisetty
Plot#92; 1-98/2/92, Kavuri Hills – Phase II, Jubilee Hills, Hyderabad, Telangana India-500033.

Specification

1. A process for the preparation of Allopurinol (1) having purity greater than
99.5% by HPLC.
5 comprising the steps of:
a) reacting 2-cyanoacetamide (5)
with triethoxymethane (4)
10 in the presence of morpholine to obtain 2-cyano-3-morpholino acrylamide
(3);
b) reacting 2-cyano-3-morpholino acrylamide (3) with hydrazine hydrate in
presence of an acid to obtain 3-amino-4-pyrazolecarboxamide (2); and
15
13
c) cyclizing 3-amino-4-pyrazolecarboxamide (2) with formamide in the
presence of a base to obtain crude Allopurinol (1), and
d) purifying crude Allopurinol (1) to obtain pure Allopurinol (1).
Wherein the purification of Allopurinol (1) comprises of
5 i. dissolving allopurinol in aqueous sodium hydroxide solution;
ii. adding neutral charcoal and heating to 40-45°C;
iii. filtering and adjusting pH of the filtrate to 4.5 using suitable
organic acid; and
iv. isolating pure Allopurinol.
10 2. The process as claimed in claim 1, wherein the acid used in step b) is selected
from sulfuric acid or hydrochloric acid.
3. The process as claimed in claim 1, wherein the base used in step c) is selected
from the group comprising “alkali hydroxides” such as sodium hydroxide,
potassium hydroxide, lithium hydroxide and the like.
15 4. The process as claimed in claim 1, wherein the suitable organic acid used is
acetic acid.

Documents

Application Documents

# Name Date
1 202341005766-PROVISIONAL SPECIFICATION [30-01-2023(online)].pdf 2023-01-30
2 202341005766-FORM 1 [30-01-2023(online)].pdf 2023-01-30
3 202341005766-DRAWINGS [30-01-2023(online)].pdf 2023-01-30
4 202341005766-Proof of Right [03-03-2023(online)].pdf 2023-03-03
5 202341005766-FORM 3 [30-01-2024(online)].pdf 2024-01-30
6 202341005766-ENDORSEMENT BY INVENTORS [30-01-2024(online)].pdf 2024-01-30
7 202341005766-DRAWING [30-01-2024(online)].pdf 2024-01-30
8 202341005766-COMPLETE SPECIFICATION [30-01-2024(online)].pdf 2024-01-30